scanance.
Sign inGet Premium
NX

Nuveen Select Tax-Free Income Portfolio

NXPFinancial ServicesNASDAQ

Asset Management · Last scanned May 29, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$9.9M
-68.8% YoY
Net Income
$9.5M
-69.6% YoY

Scan Results

Daily timeframe
DateIndicatorDetails
Loading...
About Nuveen Select Tax-Free Income Portfolio

Part of the financial services sector, Nuveen Select Tax-Free Income Portfolio (NXP) is listed under Asset Management. At a $740.1M market cap, Nuveen Select Tax-Free Income Portfolio ranks as a small-cap company within financial services. The fund is co-managed by Nuveen Fund Advisors LLC and Nuveen Asset Management, LLC.

Key stats
Market Cap$740.1M
P/E (TTM)94.87
EPS$0.15
Beta0.34
52W Change+1.1%
Dividend Yield4.51%
ROE1.1%
Analysis

Nuveen Select Tax-Free Income Portfolio reports $7.4M in cash and $0 in total debt. Return on equity stands at 1.1%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.7% is on the lower side, which is common in asset-heavy industries. Revenue has grown from -$43.7M (2022) to $9.9M (2025), reflecting a 123% increase over the period.

With a beta below 0.7, Nuveen Select Tax-Free Income Portfolio typically sees smaller price swings than the overall market, offering a degree of stability during turbulent periods. At over 50x earnings, NXP carries valuation risk — any slowdown in growth expectations could lead to meaningful price adjustments. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Nuveen Select Tax-Free Income Portfolio's trajectory.

Links
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms